Instalab

Alternaria Alternata (Alt a 6) IgE Test Blood

Spot a hidden mold trigger behind your asthma or eczema flares, beyond what a basic allergy panel can show.

Should you take a Alternaria Alternata (Alt a 6) IgE test?

This test is most useful if any of these apply to you.

Living With Eczema and Asthma
When skin and lungs both flare, mold may be a shared trigger. This test checks for one of the components most linked to that overlap.
Asthma That Flares in Damp Weather
If your wheezing tracks with humidity, basements, or rainy seasons, this test helps confirm whether mold sensitization is part of the pattern.
Nasal Symptoms No One Can Explain
Year-round congestion or hay fever that doesn't match obvious pollen seasons may point to indoor mold. This test adds a piece to that puzzle.
Mapping Your Full Allergy Profile
If you already know you react to Alternaria or Alt a 1, this test fills in a component that standard panels often miss.

About Alternaria Alternata (Alt a 6) IgE

If you have asthma that flares in damp weather, eczema that won't quiet down, or stubborn nasal symptoms that follow you indoors and outdoors, mold may be playing a role you haven't yet identified. Alternaria alternata is one of the most common allergy-relevant molds worldwide, and your immune system can recognize several different proteins inside it. This test zeroes in on one of those proteins.

Alt a 6 (the full name is Alternaria alternata enolase) is a minor mold protein that some people make antibodies against. Most people sensitized to Alternaria react to a different protein called Alt a 1, but a subset also recognize Alt a 6, and that subset tends to look different clinically, especially when eczema and asthma overlap.

What This Test Actually Measures

This is a blood test that looks for IgE (immunoglobulin E) antibodies aimed at Alt a 6 specifically. IgE is the antibody class your body uses to flag allergens. When IgE finds its target, it sets off the cascade that produces hives, wheezing, runny nose, itchy skin, and other allergic symptoms.

Alt a 6 itself is an enzyme called an enolase. Enolases show up across many fungi, which means antibodies to Alt a 6 can also react to enolases from other molds. So a positive result tells you two things at once: your body has met Alternaria, and you may have broader mold cross-reactivity baked into your immune memory.

This is a research-grade marker. There are no universally standardized cutpoints for Alt a 6 specifically, and clinical decisions about mold allergy and immunotherapy are still driven mostly by Alt a 1 and whole Alternaria extract testing. Alt a 6 adds detail, not a diagnosis on its own.

Asthma Risk and the Atopic Dermatitis Link

The clearest signal in the research is that people with eczema (atopic dermatitis) who also have asthma show Alt a 6 antibodies more often than those with eczema alone. In a study of 100 adults with atopic dermatitis tested on the ALEX2 multiplex panel, the Alternaria enolase Alt a 6 was identified as an important molecular component in patients with concomitant asthma.

A separate analysis in the same cohort found that high IgE to Alt a 6 was significantly more frequent in atopic dermatitis patients who also had bronchial asthma. Translating that into practical terms: if you have eczema and your skin and lungs both seem to flare in damp or moldy environments, finding antibodies to Alt a 6 supports the case that mold is a shared trigger across both organs.

Alternaria sensitization in general is associated with more severe asthma, particularly type 2-high asthma (the inflammation pattern driven by allergic immune cells). In a study of 582 patients comparing type 2-high to type 2-low Alternaria asthma, type 2-high patients had higher total IgE, higher specific IgE levels, and were more often polysensitized (allergic to several things at once).

Allergic Rhinitis and Nasal Symptoms

Alternaria is a recognized driver of allergic rhinitis (hay fever) and rhinoconjunctivitis (itchy, watery eyes and nose together). In a 2011 US population analysis of about 8,000 people, mold-specific IgE was independently associated with self-reported allergy symptoms, alongside plant and pet allergens.

Alt a 6 itself is rarely the headliner for nasal symptoms (Alt a 1 dominates that story), but a positive Alt a 6 confirms genuine mold sensitization rather than nonspecific reactivity. If your nasal symptoms get worse in damp basements, after lawn work, or during humid summers, Alternaria is one of the molds most likely involved.

Why Alt a 6 Is a Minor Allergen, and Why That Still Matters

In a study of 64 patients with Alternaria allergy, only 12.5% had IgE to Alt a 4 and/or Alt a 6, while 98.4% had IgE to Alt a 1. That makes Alt a 6 a minor allergen by prevalence: most Alternaria-allergic people will not react to it.

This sounds like a reason to skip the test, but it isn't. The 12.5% who do react to Alt a 6 tend to have a more complex allergic picture, often with asthma layered onto eczema or rhinitis. And because enolases cross-react across fungal species, a positive Alt a 6 hints at broader mold sensitization that whole-extract Alternaria testing can miss.

Reconciling the Mixed Picture

You may read that Alternaria allergy is common and clinically important in one part of the world and rare and minor in another. Both can be true. In Spain, Alternaria sensitization is highly prevalent and Alt a 1 is a leading allergen source. In Finland, IgE-mediated sensitization to Alternaria was rare and of minor clinical importance in a study of 7,927 patients. Climate, indoor environments, and regional mold loads drive the difference.

This isn't a contradiction in the biology. It means the value of testing depends on where you live, what your indoor environment looks like, and whether your symptoms pattern with mold exposure. A positive Alt a 6 in someone with mold-pattern symptoms is meaningful regardless of regional averages.

Tracking Your Trend Over Time

A single Alt a 6 reading tells you whether your immune system has met this protein. The bigger value comes from watching the trend, especially if you're doing allergen immunotherapy, making environmental changes, or trying a new medication. Specific IgE levels can shift as exposure changes, as treatment progresses, or as your immune system adapts.

A reasonable approach: get a baseline now, retest in 6 to 12 months if you've made meaningful changes (new home, new humidifier strategy, started allergen immunotherapy, started a biologic for asthma), and at least annually thereafter if mold sensitization is part of your clinical picture. A falling Alt a 6 after immunotherapy is one signal among many that the treatment is reshaping your immune response. Note that current immunotherapy products target Alt a 1, not Alt a 6, so changes in Alt a 6 are observational rather than therapeutic targets.

When Results Can Be Misleading

A few situations can shift the picture of what Alt a 6 IgE means for you:

  • Cross-reactivity with other fungal enolases: because enolases are similar across many fungi, a positive Alt a 6 may reflect sensitization to other molds you've encountered, not just Alternaria. The test cannot tell you which fungal exposure drove the antibody response.
  • Polysensitization muddying attribution: many Alternaria-sensitized people are also sensitized to dust mites, pollens, and pets. A positive Alt a 6 confirms mold sensitization, but does not prove that mold is the dominant driver of your symptoms.
  • Regional and seasonal context: Alternaria exposure varies sharply by climate, season, and indoor mold load. A positive test in a low-exposure region may carry less day-to-day symptom relevance than the same result in a high-exposure region.
  • Skin test vs blood test mismatch: in children and adolescents with Alternaria allergy, the correlation between skin prick test results and specific IgE levels was only weak to moderate in a study of 149 patients. A normal skin test does not rule out blood IgE sensitization, and vice versa.

What to Do With an Unexpected Result

A positive Alt a 6 by itself does not diagnose a disease, and a negative result does not rule out Alternaria allergy (you may still react to Alt a 1 or whole extract). The right next step depends on what else you're seeing.

If you have asthma or eczema that hasn't been linked to a specific trigger, a positive Alt a 6 should prompt a wider workup: total IgE, Alt a 1 specifically, whole Alternaria extract IgE, and a panel covering dust mites, pollens, and pets. An allergist or immunologist can connect those numbers to your symptom history and decide whether allergen immunotherapy, environmental remediation, or biologic therapy makes sense.

If you have eczema plus asthma, a positive Alt a 6 strengthens the case for evaluating mold as a shared driver. Look at your home environment: damp basements, leaky bathrooms, humidifiers, indoor plants, and HVAC filters are common sources. If symptoms cluster in specific rooms or seasons, that pattern matters more than any single lab number.

If your result is negative but you suspect mold, do not stop there. Alt a 6 is a minor allergen; most Alternaria-sensitized people will not have antibodies to it. Alt a 1 and whole Alternaria extract testing are the higher-yield next steps.

What Moves This Biomarker

Evidence-backed interventions that affect your Alternaria Alternata (Alt a 6) IgE level

Up & Down
Subcutaneous immunotherapy with Alt a 1 (the major Alternaria allergen)
Allergen immunotherapy reshapes your immune response to Alternaria over months to years. In a study of 64 patients treated with Alt a 1 immunotherapy, the sensitization pattern to Alternaria allergens shifted, with desensitization and reduced symptoms and medication use. Specific IgE typically rises briefly in the early weeks before declining over the longer term. This evidence is about Alt a 1, not Alt a 6 directly. The effect on Alt a 6 IgE has not been quantified in the available trials.
MedicationModerate Evidence
Up & Down
Subcutaneous immunotherapy with whole Alternaria alternata extract
In a randomized placebo-controlled trial of 28 patients with Alternaria-related rhinitis, asthma, or both, immunotherapy with whole Alternaria extract reduced conjunctival reactivity and produced significant immunologic changes including IgG4 increases and longer-term IgE remodeling. The trial reported on extract-specific and Alt a 1 IgE rather than Alt a 6 specifically, so the effect on Alt a 6 IgE has not been directly measured.
MedicationModerate Evidence
Up & Down
Polymerized Alt a 1 allergoid subcutaneous immunotherapy
In a pilot study of 42 children with allergic rhinitis sensitized to Alternaria, a polymerized Alt a 1 immunotherapy product reduced nasal nitric oxide, improved nasal airflow, and produced a short-term rise in Alt a 1 specific IgE consistent with immune remodeling. The study did not separately track Alt a 6 IgE, so changes in this specific marker were not reported.
MedicationModerate Evidence

Frequently Asked Questions

References

24 studies
  1. Rodríguez D, Tabar a, Castillo M, Martínez-gomariz M, Dobski IC, Palacios RJournal of Fungi2021
  2. ČElakovská J, Bukac J, Cermakova E, Vankova R, Skalská H, Krejsek J, Andrys CInternational Journal of Molecular Sciences2021
  3. Asturias J, Ibarrola I, Ferrer a, Andréu C, López-pascual E, Quiralte J, Florido F, Martínez aThe Journal of Allergy and Clinical Immunology2005